Durability of Response and gender-based analysis from the LINC3 Trial of Osilodrostat in the Treatment in Cushing's Disease

European Society of Endocrinology
9/8/20, 5:00 PM
Europe/Paris GMT+2

Description

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Niki Karavitaki

Inglês

 

Speakers

Rosario Pivonello